1. Lopez , AD , Mathers , CD , Ezzati , M , et al . ( 2006 ) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data . Lancet 367 , 1747 – 1757 .

2. Gu , D , Reynolds , K , Wu , X , et al . ( 2002 ) Prevalence, awareness, treatment, and control of hypertension in China . Hypertension 40 , 920 – 927 .

3. Kearney , PM , Whelton , M , Reynolds , K , et al . ( 2005 ) Global burden of hypertension: analysis of worldwide data . Lancet 365 , 217 – 223 .

4. Zhang , Y , Shao , L , Ma , A , et al . ( 2014 ) Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway . Hypertens Res 37 , 43 – 49 .

5. Devereux , RB & Roman , MJ ( 1999 ) Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences . Hypertens Res 22 , 1 – 9 .

6. Katz , AM ( 1990 ) Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure . N Engl J Med 322 , 100 – 110 .

7. Higashi , Y , Noma , K , Yoshizumi , M , et al . ( 2009 ) Endothelial function and oxidative stress in cardiovascular diseases . Circ J 73 , 411 – 418 .

8. Sanada , S , Node , K , Minamino , T , et al . ( 2003 ) Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats . Hypertension 41 , 963 – 967 .

9. Rossi , MA & Colombini-Netto , M ( 2001 ) Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta . J Hypertens 19 , 1567 – 1579 .

10. Ferreira , RN , Rocha , VN , da Silva Torres , T , et al . ( 2011 ) Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats . Exp Toxicol Pathol 63 , 473 – 478 .

11. Kumar , S , Saravanakumar , M & Raja , B ( 2010 ) Efficacy of piperine, an alkaloidal constituent of pepper on nitric oxide, antioxidants and lipid peroxidation markers in l -NAME induced hypertensive rats . Int J Res Pharm Sci 1 , 300 – 307 .

12. Retelny , VS , Neuendorf , A & Roth , JL ( 2008 ) Nutrition protocols for the prevention of cardiovascular disease . Nutr Clin Pract 23 , 468 – 476 .

13. Kumar , S , Prahalathan , P & Raja , B ( 2011 ) Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in l -NAME-induced hypertensive rats: a dose-dependence study . Redox Rep 16 , 208 – 215 .

14. Narasimhan , B , Ohlan , S , Ohlan , R , et al . ( 2009 ) Hansch analysis of veratric acid derivatives as antimicrobial agents . Eur J Med Chem 44 , 689 – 700 .

15. Szwajgier , D , Pielecki , J , Targonski , Z , et al . ( 2005 ) Antioxidant activity of cinnamic and benzoic acid derivatives . Acta Sci Pol Technol Aliment 4 , 129 – 149 .

16. Mattila , P & Kumpulainen , J ( 2002 ) Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection . J Agric Food Chem 50 , 3660 – 3667 .

17. Saravanakumar , M & Raja , B ( 2011 ) Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in l -NAME induced hypertensive rats . Eur J Pharmacol 671 , 87 – 94 .

18. Saravanakumar , M & Raja , B ( 2012 ) Effect of veratric acid on the cardiovascular risk of l -NAME-induced hypertensive rats . J Cardiovasc Pharmacol 59 , 553 – 562 .

19. Niehaus , WG Jr & Samuelsson , B ( 1968 ) Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation . Eur J Biochem 6 , 126 – 130 .

20. Jiang , ZY , Hunt , JV & Wolff , SP ( 1992 ) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein . Anal Biochem 202 , 384 – 389 .

21. Kakkar , P , Das , B & Viswanathan , PN ( 1984 ) A modified spectrophotometric assay of superoxide dismutase . Indian J Biochem Biophys 21 , 130 – 132 .

22. Sinha , AK ( 1972 ) Colorimetric assay of catalase . Anal Biochem 47 , 389 – 394 .

23. Rotruck , JT , Pope , AL , Ganther , HE , et al . ( 1973 ) Selenium: biochemical role as a component of glutathione peroxidase . Science 179 , 588 – 590 .

24. Ellman , GL ( 1959 ) Tissue sulfhydryl groups . Arch Biochem Biophys 82 , 70 – 77 .

25. Roe , JH & Kuether , CA ( 1943 ) The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative of dehydroascorbic acid . J Biol Chem 147 , 399 – 407 .

26. Baker , H , Frank , O , DeAngelis , B , et al . ( 1980 ) Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol . Nutr Rep Int 21 , 531 – 536 .

27. Fenning , A , Harrison , G , Rose'meyer , R , et al . ( 2005 ) L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats . Am J Physiol Heart Circ Physiol 289 , H1408 – H1416 .

28. Rajasekaran , D , Manoharan , S , Silvan , S , et al . ( 2012 ) Proapoptotic, anti-cell proliferative, anti-inflammatory and anti-angiogenic potential of carnosic acid during 7,12 dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis . Afr J Tradit Complement Altern Med 10 , 102 – 112 .

29. Katsumi , H , Nishikawa , M & Hashida , M ( 2007 ) Development of nitric oxide donors for the treatment of cardiovascular diseases . Cardiovasc Hematol Agents Med Chem 5 , 204 – 208 .

30. Boe , AE , Eren , M , Murphy , SB , et al . ( 2013 ) Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence . Circulation 128 , 2318 – 2324 .

31. Yang , HY , Yang , SC , Chen , ST , et al . ( 2008 ) Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l -NAME-induced hypertension . J Nutr Biochem 19 , 833 – 839 .

32. Ulker , S , McKeown , PP & Bayraktutan , U ( 2003 ) Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities . Hypertension 41 , 534 – 539 .

33. Ndisang , JF & Chibbar , R ( 2014 ) Heme oxygenase improves renal function by potentiating podocyte-associated proteins in Nω-nitro- l -arginine-methyl ester ( l -NAME)-induced hypertension . Am J Hypertens 28 , 930 – 942 .

34. Paulis , L , Zicha , J , Kunes , J , et al . ( 2008 ) Regression of l -NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor . Hypertens Res 31 , 793 – 803 .

35. Dikalov , SI & Ungvari , Z ( 2013 ) Role of mitochondrial oxidative stress in hypertension . Am J Physiol Heart Circ Physiol 305 , H1417 – H1427 .

36. Rodrigo , R , Libuy , M , Feliú , F , et al . ( 2013 ) Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage . Dis Markers 35 , 773 – 790 .

37. Senthil , S , Veerappan , RM , Ramakrishna Rao , M , et al . ( 2004 ) Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction . Clin Chim Acta 348 , 131 – 137 .

38. Seifi , B , Kadkhodaee , M , Karimian , SM , et al . ( 2010 ) Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage . Clin Exp Hypertens 32 , 90 – 97 .

39. Karthikeyan , J & Rani , P ( 2003 ) Enzymatic and non-enzymatic antioxidants in selected Piper species . Indian J Exp Biol 41 , 135 – 140 .

40. Abidi , P , Afaq , F , Arif , JM , et al . ( 1999 ) Chrysotile-mediated imbalance in the glutathione redox system in the development of pulmonary injury . Toxicol Lett 106 , 31 – 39 .

41. Newaz , MA & Nawal , NN ( 1999 ) Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR) . Clin Exp Hypertens 21 , 1297 – 1313 .

42. Hiremath , P , Bauer , M , Aguirre , AD , et al . ( 2014 ) Identifying early changes in myocardial microstructure in hypertensive heart disease . PLOS ONE 9 , e97424 .

43. Chatziantoniou , C & Dussaule , JC ( 2005 ) Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289 , F227 – F234 .

44. Olzinski , AR , McCafferty , TA , Zhao , SQ , et al . ( 2005 ) Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection . Cardiovasc Res 66 , 170 – 178 .

45. de Gasparo , M , Hess , P , Nuesslein-Hildesheim , B , et al . ( 2000 ) Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction . J Renin Angiotensin Aldosterone Syst 1 , 151 – 158 .

46. Mattson , DL , Kunert , MP , Roman , RJ , et al . ( 2005 ) Substitution of chromosome 1 ameliorates l -NAME hypertension and renal disease in the fawn-hooded hypertensive rat . Am J Physiol Renal Physiol 288 , F1015 – F1022 .

47. Mulvany , MJ , Baumbach , GL , Aalkjaer , C , et al . ( 1996 ) Vascular remodeling . Hypertension 28 , 505 – 506 .

48. Nadruz , W ( 2015 ) Myocardial remodeling in hypertension . J Hum Hypertens 29 , 1 – 6 .

49. Díez , J , Querejeta , R , López , B , et al . ( 2002 ) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients . Circulation 105 , 2512 – 2517 .

50. Manabe , I , Shindo , T & Nagai , R ( 2002 ) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy . Circ Res 91 , 1103 – 1113 .

51. Mapanga , RF , Rajamani , U , Dlamini , N , et al . ( 2002 ) Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction . PLoS ONE 7 , e47322 .

52. Versari , D , Daghini , E , Virdis , A , et al . ( 2009 ) Endothelium-dependent contractions and endothelial dysfunction in human hypertension . Br J Pharmacol 157 , 527 – 536 .

53. Török , J ( 2008 ) Participation of nitric oxide in different models of experimental hypertension . Physiol Res 57 , 813 – 825 .

54. Chen , B , Shi , L , Yu , X , et al . ( 2012 ) Differential effects of Rho-kinase inhibitor and angiotensin II type-1 receptor antagonist on the vascular function in hypertensive rats induced by chronic l -NAME treatment . Acta Pharm Sin B 2 , 450 – 458 .

55. Kung , CF , Moreau , P , Takase , H , et al . ( 1995 ) l -NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil . Hypertension 26 , 744 – 751 .

56. Fan , D , Takawale , A , Lee , J , et al . ( 2012 ) Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease . Fibrogenesis Tissue Repair 5 , 15 .

57. Ammarguellat , FZ , Gannon , PO , Amiri , F , et al . ( 2002 ) Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors . Hypertension 39 , 679 – 684 .